These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35032682)

  • 1. Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression Study.
    Dhami P; Quilty LC; Schwartzmann B; Uher R; Allen TA; Kloiber S; Lam RW; MacQueen G; Frey BN; Milev R; Müller DJ; Strother SC; Blier P; Soares CN; Parikh SV; Turecki G; Foster JA; Rotzinger S; Kennedy SH; Farzan F
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Feb; 8(2):162-170. PubMed ID: 35032682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report.
    Chakrabarty T; McInerney SJ; Torres IJ; Frey BN; Milev RV; Müller DJ; Rotzinger S; Kennedy SH; Lam RW;
    CNS Drugs; 2021 Mar; 35(3):291-304. PubMed ID: 33683582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report.
    Dunlop K; Rizvi SJ; Kennedy SH; Hassel S; Strother SC; Harris JK; Zamyadi M; Arnott SR; Davis AD; Mansouri F; Schulze L; Ceniti AK; Lam RW; Milev R; Rotzinger S; Foster JA; Frey BN; Parikh SV; Soares CN; Uher R; Turecki G; MacQueen GM; Downar J
    Neuropsychopharmacology; 2020 Jul; 45(8):1390-1397. PubMed ID: 32349119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
    van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.
    Lam RW; Milev R; Rotzinger S; Andreazza AC; Blier P; Brenner C; Daskalakis ZJ; Dharsee M; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Geraci J; Giacobbe P; Feilotter HE; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; Liotti M; MacQueen GM; McAndrews MP; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Salomons TV; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Kennedy SH;
    BMC Psychiatry; 2016 Apr; 16():105. PubMed ID: 27084692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connectivity of the Cognitive Control Network During Response Inhibition as a Predictive and Response Biomarker in Major Depression: Evidence From a Randomized Clinical Trial.
    Tozzi L; Goldstein-Piekarski AN; Korgaonkar MS; Williams LM
    Biol Psychiatry; 2020 Mar; 87(5):462-472. PubMed ID: 31601424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exploratory analysis of Go/Nogo event-related potentials in major depression and depression following traumatic brain injury.
    Bailey NW; Hoy KE; Maller JJ; Segrave RA; Thomson R; Williams N; Daskalakis ZJ; Fitzgerald PB
    Psychiatry Res; 2014 Dec; 224(3):324-34. PubMed ID: 25452196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
    Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
    Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impulsivity in Major Depressive Disorder Patients with Suicidal Ideation: Event-related Potentials in a GoNogo Task.
    Kim M; Lee YJ; Hwang J; Woo SI; Hahn SW
    Clin Psychopharmacol Neurosci; 2023 Nov; 21(4):787-797. PubMed ID: 37859452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1.
    McInerney SJ; Chakrabarty T; Maciukiewicz M; Frey BN; MacQueen GM; Milev RV; Ravindran AV; Rotzinger S; Kennedy SH; Lam RW;
    Can J Psychiatry; 2021 Sep; 66(9):798-806. PubMed ID: 33353384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.
    Ananth MR; DeLorenzo C; Yang J; Mann JJ; Parsey RV
    J Nucl Med; 2018 Apr; 59(4):665-670. PubMed ID: 28935838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship Between Response-Inhibitory Event-Related Potentials and Symptoms of Attention-Deficit/Hyperactivity Disorder in Adult Patients with Major Depressive Disorder.
    Kim EJ; Kwon YJ; Lee HY; Yoon HJ; Kim JS; Shim SH
    Psychiatry Investig; 2020 Oct; 17(10):996-1005. PubMed ID: 33045796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological evidence for reduced inhibitory control in depressed patients in partial remission: a Go/Nogo study.
    Ruchsow M; Groen G; Kiefer M; Beschoner P; Hermle L; Ebert D; Falkenstein M
    Int J Psychophysiol; 2008 Jun; 68(3):209-18. PubMed ID: 18313159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report.
    Morton E; Bhat V; Giacobbe P; Lou W; Michalak EE; McInerney S; Chakrabarty T; Frey BN; Milev RV; Müller DJ; Parikh SV; Rotzinger S; Kennedy SH; Lam RW;
    CNS Drugs; 2021 Apr; 35(4):439-450. PubMed ID: 33860922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine.
    Sun Y; Drevets W; Turecki G; Li QS
    Brain Behav Immun; 2020 Jul; 87():404-412. PubMed ID: 31978524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study.
    Alders GL; Davis AD; MacQueen G; Strother SC; Hassel S; Zamyadi M; Sharma GB; Arnott SR; Downar J; Harris JK; Lam RW; Milev R; Müller DJ; Ravindran A; Kennedy SH; Frey BN; Minuzzi L; Hall GB;
    J Affect Disord; 2020 Mar; 264():414-424. PubMed ID: 31757619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P300 amplitude during a monetary incentive delay task predicts future therapy completion in individuals with major depressive disorder.
    White EJ; Nacke M; Akeman E; Cannon MJ; Mayeli A; Touthang J; Zoubi OA; McDermott TJ; Kirlic N; Santiago J; Kuplicki R; Bodurka J; Paulus MP; Craske MG; Wolitzky-Taylor K; Abelson J; Martell C; Clausen A; Stewart JL; Aupperle RL
    J Affect Disord; 2021 Dec; 295():873-882. PubMed ID: 34706458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol.
    Köhler-Forsberg K; Jorgensen A; Dam VH; Stenbæk DS; Fisher PM; Ip CT; Ganz M; Poulsen HE; Giraldi A; Ozenne B; Jørgensen MB; Knudsen GM; Frokjaer VG
    Front Psychiatry; 2020; 11():641. PubMed ID: 32792991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of escitalopram therapy on functional brain controllability in major depressive disorder.
    Fang F; Godlewska B; Cho RY; Savitz SI; Selvaraj S; Zhang Y
    J Affect Disord; 2022 Aug; 310():68-74. PubMed ID: 35500684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive impairment of mental rotation in major depressive disorder: evidence from event-related brain potentials.
    Chen J; Ma W; Zhang Y; Yang LQ; Zhang Z; Wu X; Deng Z
    J Nerv Ment Dis; 2014 Aug; 202(8):594-602. PubMed ID: 25010105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.